MapLight Therapeutics, Inc.
MPLTNasdaqCIK 1770069HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2024-03-31 | period not labelled2024-06-30 | period not labelled2024-09-30 | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $m | not reported | not reported | 16.8Research and development, period not labelled, three months to 2024-09-30$16.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 20.7Research and development, period not labelled, three months to 2024-12-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | 19.8Research and development, period not labelled, three months to 2025-03-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 26.8Research and development, period not labelled, three months to 2025-06-30$26.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 27.1Research and development, Q3 FY2025, three months to 2025-09-30$27.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 64.6Research and development, Q4 FY2025, three months to 2025-12-31$64.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | 53.7Research and development, Q1 FY2026, three months to 2026-03-31$53.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 53.4Research and development, Q2 FY2026, three months to 2026-06-30$53.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Operating income | $m | not reported | not reported | (20.9)Operating income, period not labelled, three months to 2024-09-30−$20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (22.8)Operating income, period not labelled, three months to 2024-12-31−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (23.5)Operating income, period not labelled, three months to 2025-03-31−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (30.7)Operating income, period not labelled, three months to 2025-06-30−$30.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (31.5)Operating income, Q3 FY2025, three months to 2025-09-30−$31.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (83.4)Operating income, Q4 FY2025, three months to 2025-12-31−$83.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (64.5)Operating income, Q1 FY2026, three months to 2026-03-31−$64.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (63.5)Operating income, Q2 FY2026, three months to 2026-06-30−$63.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Net income | $m | (18.9)Net income, period not labelled, three months to 2024-03-31−$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (18.4)Net income, period not labelled, three months to 2024-06-30−$18.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (19.0)Net income, period not labelled, three months to 2024-09-30−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (21.2)Net income, period not labelled, three months to 2024-12-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (22.3)Net income, period not labelled, three months to 2025-03-31−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (29.8)Net income, period not labelled, three months to 2025-06-30−$29.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (29.4)Net income, Q3 FY2025, three months to 2025-09-30−$29.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (79.5)Net income, Q4 FY2025, three months to 2025-12-31−$79.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (60.7)Net income, Q1 FY2026, three months to 2026-03-31−$60.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (60.2)Net income, Q2 FY2026, three months to 2026-06-30−$60.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | (25.08)Diluted EPS, period not labelled, three months to 2024-09-30−$25.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | not reported | (29.33)Diluted EPS, period not labelled, three months to 2025-03-31−$29.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (39.11)Diluted EPS, period not labelled, three months to 2025-06-30−$39.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (37.18)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$37.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | not reported | (1.34)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (1.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Basic EPS | $ per share | not reported | not reported | (25.08)Basic EPS, period not labelled, three months to 2024-09-30−$25.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | not reported | (29.33)Basic EPS, period not labelled, three months to 2025-03-31−$29.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (39.11)Basic EPS, period not labelled, three months to 2025-06-30−$39.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (37.18)Basic EPS, Q3 FY2025, three months to 2025-09-30−$37.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | not reported | (1.34)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (1.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2023-12-31 | period not labelled2024-03-31 | period not labelled2024-06-30 | period not labelled2024-09-30 | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | 38.3Cash and equivalents, period not labelled, at 2024-12-31$38.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | not reported | not reported | 64.1Cash and equivalents, Q3 FY2025, at 2025-09-30$64.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 46.7Cash and equivalents, FY2025, at 2025-12-31$46.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 55.7Cash and equivalents, Q1 FY2026, at 2026-03-31$55.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 71.6Cash and equivalents, Q2 FY2026, at 2026-06-30$71.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Current assets | $m | not reported | not reported | not reported | not reported | 115Current assets, period not labelled, at 2024-12-31$114.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | not reported | not reported | 245Current assets, Q3 FY2025, at 2025-09-30$245.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 325Current assets, FY2025, at 2025-12-31$324.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 327Current assets, Q1 FY2026, at 2026-03-31$327.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 319Current assets, Q2 FY2026, at 2026-06-30$318.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Total assets | $m | not reported | not reported | not reported | not reported | 137Total assets, period not labelled, at 2024-12-31$136.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | not reported | not reported | 257Total assets, Q3 FY2025, at 2025-09-30$257.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 480Total assets, FY2025, at 2025-12-31$479.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 419Total assets, Q1 FY2026, at 2026-03-31$418.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 368Total assets, Q2 FY2026, at 2026-06-30$368.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | not reported | 15.9Current liabilities, period not labelled, at 2024-12-31$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | not reported | not reported | 18.6Current liabilities, Q3 FY2025, at 2025-09-30$18.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 16.2Current liabilities, FY2025, at 2025-12-31$16.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 14.3Current liabilities, Q1 FY2026, at 2026-03-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 19.3Current liabilities, Q2 FY2026, at 2026-06-30$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Total liabilities | $m | not reported | not reported | not reported | not reported | 21.7Total liabilities, period not labelled, at 2024-12-31$21.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | not reported | not reported | 23.7Total liabilities, Q3 FY2025, at 2025-09-30$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 21.1Total liabilities, FY2025, at 2025-12-31$21.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 19.0Total liabilities, Q1 FY2026, at 2026-03-31$19.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 20.0Total liabilities, Q2 FY2026, at 2026-06-30$20.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
| Shareholders' equity | $m | (118)Shareholders' equity, period not labelled, at 2023-12-31−$117.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001193125-26-125072.Report this figure | (136)Shareholders' equity, period not labelled, at 2024-03-31−$136.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (154)Shareholders' equity, period not labelled, at 2024-06-30−$154.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (172)Shareholders' equity, period not labelled, at 2024-09-30−$172.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | (194)Shareholders' equity, period not labelled, at 2024-12-31−$193.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (216)Shareholders' equity, period not labelled, at 2025-03-31−$215.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (245)Shareholders' equity, period not labelled, at 2025-06-30−$245.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | (274)Shareholders' equity, Q3 FY2025, at 2025-09-30−$274.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-04, accession 0001193125-25-307453.Report this figure | 458Shareholders' equity, FY2025, at 2025-12-31$458.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 400Shareholders' equity, Q1 FY2026, at 2026-03-31$399.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure | 348Shareholders' equity, Q2 FY2026, at 2026-06-30$348.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349554.Report this figure |
Cash flow
| Line item | Unit | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (21.5)Operating cash flow, period not labelled, three months to 2024-12-31−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (25.6)Operating cash flow, period not labelled, three months to 2025-03-31−$25.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (34.0)Operating cash flow, period not labelled, three months to 2025-06-30−$34.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349554. Derived: 6-month figure less the 3-month figure.Report this figure | (31.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$31.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-04, accession 0001193125-25-307453. Derived: 9-month figure less the 6-month figure.Report this figure | (46.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$46.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | (51.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$51.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | (44.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$44.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349554. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.1Capital expenditure, period not labelled, three months to 2024-12-31$106.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | 0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-04, accession 0001193125-25-307453. Derived: 9-month figure less the 6-month figure.Report this figure | 0.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$376.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-125072. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224129.Report this figure | 0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349554. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2024-09-30 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 0.8 | 0.8 | 0.8 | 0.8 | 45.3 | 45.4 |
Shares outstanding: 42.44m at Mar 19, 2026, from the cover of the 10-K filed Mar 26, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.